To my fellow colleagues,
My name is Celia Chessin-Yudin and I am a Program Associate at PATH, a global organization with a mission to advance health equity through innovation and partnerships. a Global Health organization based in Seattle, WA working in over 70 countries worldwide. I work in the Diagnostics Program at PATH and I am reaching out to all of you now because we are starting a landscaping exercise to identify companies working on G6PD tests that may benefit from our evaluation. Please take a look at the call linked in this post. If you know of companies developing G6PD tests that may want to be evaluated we would greatly appreciate you sending them this call.
I am also attaching the link on our website here: https://www.path.org/resources/call-evaluations-new-rapid-diagnostics-test-improve-access-g6pd-deficiency-testing-emerging-markets/.